Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer

Miao Dai,Bikang Yang,Jing Chen,Fei Liu,Yanjie Zhou,Yang Zhou,Qinyang Xu,Shuheng Jiang,Shujie Zhao,Xinchun Li,Xuan Zhou,Qin Yang,Jun Li,Yahui Wang,Zhigang Zhang,Yincheng Teng

DOI: https://doi.org/10.1016/j.canlet.2021.04.024

IF: 9.756

2021-08-01

Cancer Letters

Abstract:<p>Endometrial cancer (EC) is becoming one of the most common gynecologic malignancies. Lipid metabolism is a hallmark feature of cancers. The molecular mechanisms underlying lipid metabolism in EC remain unclear. In this study, we revealed that many lipid metabolism-related genes were aberrantly expressed in endometrial cancer tissues, especially ACLY. Upregulated ACLY promoted EC cell proliferation and colony formation, and attenuated apoptosis. Mechanistically, cotreatment with obesity-related factors (estradiol, insulin and leptin) promoted nuclear translocation of ACLY through Akt-mediated phosphorylation of ACLY at Ser455. Nuclear-localized ACLY increased histone acetylation levels, thus resulting in upregulation of pyrimidine metabolism genes, such as DHODH. Moreover, STAT3 altered the ACLY expression at the transcriptional level via directly binding to its promoter region. In conclusion, our findings clarify the roles and mechanisms of ACLY in endometrial cancer and ACLY could link obesity risk factors to the regulation of histone acetylation. We believe that novel therapeutic strategies for EC can be designed by targeting the ACLY axis.</p>

oncology

What problem does this paper attempt to address?

The problem this paper attempts to address is the investigation of the abnormal expression and mechanisms of fat metabolism-related genes in Endometrial Cancer (EC), particularly the role of ATP-citrate lyase (ACLY) in enhancing pyrimidine metabolism through the regulation of histone acetylation under the influence of obesity-related factors. Specifically, the researchers found that ACLY is significantly upregulated in endometrial cancer tissues, and this upregulation is associated with increased cell proliferation, enhanced colony formation ability, and reduced apoptosis. Further studies revealed that obesity-related factors (such as estradiol, insulin, and leptin) can promote the nuclear translocation of ACLY through Akt-mediated phosphorylation at serine 455, thereby increasing histone acetylation levels and leading to the upregulation of pyrimidine metabolism genes (such as DHODH). Additionally, signal transducer and activator of transcription 3 (STAT3) directly binds to the ACLY promoter region at the transcriptional level, altering ACLY expression. These findings not only elucidate the role and mechanism of ACLY in endometrial cancer but also suggest that the ACLY axis may become a new target for the treatment of endometrial cancer.